The patient HER2 of breast cancer measures the expected every laboratory of the whole country of the result to mutually recognize

The patient HER2 of breast cancer measures the expected every laboratory of the whole country of the result to mutually recognize
Author: Hatred entangles latest a nationwide research to reveal, only 57% of the breast cancer patients carry on HER2 (the human epidermis growth factor receptor 2) Detection. In at HER2 that hold recently measure, accuse of, authorize project, can start, Chinese Medical Association pathologic credit know General Board, Chen Jie Professor, Vice President of BJ Union Hospital, say, the breast cancer patient should carry on HER2 and measure states and types of judging tumour in an all-round way as soon as possible, so as not to lose and treat the opportunity best by mistake. Mammary gland centre director Professor Sun Qiang of BJ Union Hospital says, HER2 pathology measures " compass " that is a preferred healing solution ,Contribute to judging fast which kind of healing solution to adopt. All breast cancer patients in American-European countries will measure HER2 after making a definite diagnosis of. In our country, HER2 measured but already popularized very much too, the expenses are very low and include in the medical insurance. But " nearly half (43%) The breast cancer patient ignores HER2 to measure " But this result reveals the situation allows of no optimist very much. Professor Chen Jie thinks, on one hand because the patient does not understand the importance that this pathology measures, the intersection of HER2 and detection method among the domestic hospital and judge standard differ greatly, measure result can't approve each other and overall level to have some relations too on the other hand. If HER2 measures the result to offset, the exactness influencing breast cancer to classify, may result in, treat excessive, or unreasonable to treat, shorten the time of surviving. This time, will be sponsored by Chinese Medical Association's pathologic credit, cover Beijing, Shanghai, Guangzhou 29 main urban the intersection of the first, second and third and HER2 of hospital, measure quality, accuse of, authorize event, aim at, raise domestic HER2 pathology, find competence, every laboratory can be mutually recognized to obtain the unit testing result of the certificate of competency in the whole country, thus help the doctor, patient to choose the rational healing solution correctly.

|